Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine
Paola Filipazzi, Roberta Valenti, Veronica Huber, et al.
Journal of Clinical Oncology (2007) Vol. 25, Iss. 18, pp. 2546-2553
Closed Access | Times Cited: 644

Showing 1-25 of 644 citing articles:

Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich, Srinivas Nagaraj
Nature reviews. Immunology (2009) Vol. 9, Iss. 3, pp. 162-174
Open Access | Times Cited: 6277
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich, Suzanne Ostrand‐Rosenberg, Vincenzo Bronte
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 253-268
Open Access | Times Cited: 3280
The tumor microenvironment and its role in promoting tumor growth
Theresa L. Whiteside
Oncogene (2008) Vol. 27, Iss. 45, pp. 5904-5912
Open Access | Times Cited: 2201
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow, Margaret K. Callahan, Christopher A. Barker, et al.
New England Journal of Medicine (2012) Vol. 366, Iss. 10, pp. 925-931
Open Access | Times Cited: 1956
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand‐Rosenberg, Pratima Sinha
The Journal of Immunology (2009) Vol. 182, Iss. 8, pp. 4499-4506
Open Access | Times Cited: 1689
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
C. Marcela Díaz‐Montero, Mohamed L. Salem, Michael I. Nishimura, et al.
Cancer Immunology Immunotherapy (2008) Vol. 58, Iss. 1, pp. 49-59
Open Access | Times Cited: 1187
History of myeloid-derived suppressor cells
James E. Talmadge, Dmitry I. Gabrilovich
Nature reviews. Cancer (2013) Vol. 13, Iss. 10, pp. 739-752
Open Access | Times Cited: 1065
Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 976
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Journal of Clinical Investigation (2010)
Open Access | Times Cited: 952
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava, Pratima Sinha, Virginia K. Clements, et al.
Cancer Research (2009) Vol. 70, Iss. 1, pp. 68-77
Open Access | Times Cited: 861
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko, Arnold H. Zea, Brian I. Rini, et al.
Clinical Cancer Research (2009) Vol. 15, Iss. 6, pp. 2148-2157
Open Access | Times Cited: 849
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine, Dmitry I. Gabrilovich
Trends in Immunology (2010) Vol. 32, Iss. 1, pp. 19-25
Open Access | Times Cited: 802
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter, Toni Weinschenk, Arnulf Stenzl, et al.
Nature Medicine (2012) Vol. 18, Iss. 8, pp. 1254-1261
Open Access | Times Cited: 768
A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
Bastian Hoechst, Lars A. Ormandy, Matthias Ballmaier, et al.
Gastroenterology (2008) Vol. 135, Iss. 1, pp. 234-243
Open Access | Times Cited: 760
Dendritic cell-based immunotherapy
Rachel Lubong Sabado, Sreekumar Balan, Nina Bhardwaj
Cell Research (2016) Vol. 27, Iss. 1, pp. 74-95
Open Access | Times Cited: 759
The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau, Paul R. Gielen, Michiel Kroesen, et al.
Immunology (2012) Vol. 138, Iss. 2, pp. 105-115
Open Access | Times Cited: 744
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
Shicheng Su, Qiang Liu, Jingqi Chen, et al.
Cancer Cell (2014) Vol. 25, Iss. 5, pp. 605-620
Open Access | Times Cited: 697
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni, Serena Zilio, Ilaria Marigo, et al.
Current Opinion in Immunology (2010) Vol. 22, Iss. 2, pp. 238-244
Closed Access | Times Cited: 620
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
Ilaria Marigo, Luigi Dolcetti, Paolo Serafini, et al.
Immunological Reviews (2008) Vol. 222, Iss. 1, pp. 162-179
Open Access | Times Cited: 603
Therapeutic cancer vaccines: past, present, and future.
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 559
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Christiane Meyer, Laurène Cagnon, Carla Costa-Nunes, et al.
Cancer Immunology Immunotherapy (2013) Vol. 63, Iss. 3, pp. 247-257
Open Access | Times Cited: 521
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3365-3376
Open Access | Times Cited: 497
Tumour-released exosomes and their implications in cancer immunity
Manuela Iero, Roberta Valenti, Veronica Huber, et al.
Cell Death and Differentiation (2007) Vol. 15, Iss. 1, pp. 80-88
Open Access | Times Cited: 480
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel, Fan Pan, Qi Zeng, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 4, pp. 1580-1589
Open Access | Times Cited: 480
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
Nataša Obermajer, Ravikumar Muthuswamy, Jamie Lesnock, et al.
Blood (2011) Vol. 118, Iss. 20, pp. 5498-5505
Open Access | Times Cited: 468
Page 1 - Next Page

Scroll to top